Here are six highlights:
1. Mr. Koblish has 25 years of medical device experience and has served on Cerapedics’ board of directors since 2013.
2. Mr. Koblish co-founded and serves as president and CEO of TELA Bio, a biosurgical reconstruction company.
3. He previously was president and CEO of Orthovita, where he oversaw its sale to Stryker for $316 milion.
4. The company also appointed Doug Kohrs to its board of directors.
5. Mr. Kohrs has served in various roles during his 35-year career in the medical device industry, including a founder, board member and executive. He currently is the managing director of Responsive Arthroscopy.
6. Mr. Kohrs founded Responsive Orthopedics, which Medtronic acquired in 2016.
More articles on biologics:
US regenerative medicine market to see 33% CAGR boost through 2022— 4 observations
Smith & Nephew to purchase regenerative medicine company for $210M: 3 points
Anika Therapeutics appoints new chief human resources officer: 5 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
